摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-硝基-N-N-丙基苯甲酰胺 | 39887-56-4

中文名称
3-硝基-N-N-丙基苯甲酰胺
中文别名
——
英文名称
3-nitro-N-propylbenzamide
英文别名
——
3-硝基-N-N-丙基苯甲酰胺化学式
CAS
39887-56-4
化学式
C10H12N2O3
mdl
MFCD00779667
分子量
208.217
InChiKey
YLLMRPZZVCEHRO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    77-78 °C
  • 沸点:
    374.8±25.0 °C(Predicted)
  • 密度:
    1.192±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    74.9
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2924299090

SDS

SDS:09268c7e39d9afe8ea267edeb3299531
查看
Material Safety Data Sheet

Section 1. Identification of the substance
3-nitro-N-propylbenzamide
Product Name:
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

Section 3. Composition/information on ingredients.
3-nitro-N-propylbenzamide
Ingredient name:
CAS number: 39887-56-4

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C10H12N2O3
Molecular weight: 208.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-硝基-N-N-丙基苯甲酰胺 在 palladium 10% on activated carbon 、 氢气盐酸 作用下, 以 乙醇乙醚二氯甲烷 为溶剂, 20.0 ℃ 、2.5 MPa 条件下, 反应 1.0h, 以93%的产率得到3-amino-N-propylbenzamide hydrochloride
    参考文献:
    名称:
    The parmodulin NRD-21 is an allosteric inhibitor of PAR1 Gq signaling with improved anti-inflammatory activity and stability
    摘要:
    Novel analogs of the allosteric, biased PAR1 ligand ML161 (parmodulin 2, PM2) were prepared in order to identify potential anti-thrombotic and anti-inflammatory compounds of the parmodulin class with improved properties. Investigations of structure-activity relationships of the western portion of the 1,3-diaminobenzene scaffold were performed using an intracellular calcium mobilization assay with endothelial cells, and several heterocycles were identified that inhibited PAR1 at sub-micromolar concentrations. The oxazole NRD-21 was profiled in additional detail, and it was confirmed to act as a selective, reversible, negative allosteric modulator of PAR1. In addition to inhibiting human platelet aggregation, it showed superior anti-inflammatory activity to ML161 in a qPCR assay measuring the expression of tissue factor in response to the cytokine TNF-alpha in endothelial cells. Additionally, NRD-21 is much more plasma stable than ML161, and is a promising lead compound for the parmodulin class for anti-thrombotic and anti-inflammatory indications.
    DOI:
    10.1016/j.bmc.2019.06.043
  • 作为产物:
    描述:
    间硝基苯甲酰氯吡啶 作用下, 以 四氢呋喃正丙胺 为溶剂, 生成 3-硝基-N-N-丙基苯甲酰胺
    参考文献:
    名称:
    Thermosensitive recording material and novel color developer compounds
    摘要:
    本发明揭示了一种热敏记录材料,包括一种片状支撑和一种热敏记录层,该热敏记录层形成在支撑的至少一个表面上,并包括一种无色或浅色染料前体和一种能够与染料前体反应并在施加热量后在其中诱导颜色形成的显色剂,其中显色剂包括由以下化学式(I)或其类似物表示的化合物:该热敏记录材料具有高灵敏度,并且可以防止白色背景部分着色和记录图像在环境抗性测试中褪色。
    公开号:
    EP1264707A3
点击查看最新优质反应信息

文献信息

  • 2,4-Pyrimidinediamine Compounds and Their Uses
    申请人:Singh Rajinder
    公开号:US20150266828A1
    公开(公告)日:2015-09-24
    The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.
    本发明提供了抑制IgE和/或IgG受体信号级联反应的2,4-嘧啶二胺化合物,该级联反应导致化学介质的释放,以及合成这些化合物的中介体和方法,以及在多种情况下使用这些化合物的方法,包括在治疗和预防由脱粒和其他由IgE和/或IgG受体信号级联反应激活引起的化学介质释放所表征、引起或相关的疾病。
  • Synthesis and anion recognition studies of new oligomethylene bis(nitrophenylureylbenzamide) receptors
    作者:José García-Elías、Adrián Ochoa-Terán、Anatoli K. Yatsimirsky、Hisila Santacruz Ortega、Karen Ochoa-Lara、Luis Miguel López-Martínez、Christian L. Castro-Riquelme、Ángel L. García、Domingo Madrigal-Peralta、Victoria Labastida-Galván、Mario Ordoñez
    DOI:10.1039/c9ra05783h
    日期:——
    new series of oligomethylene bis(nitrophenylureylbenzamide) receptors were synthesized varying the relative position of the urea and amide groups (ortho 4 and meta 8) and the length of the oligomethylene chain (C2 to C8). An anion recognition study was performed with TBAX salts (X = AcO−, BzO−, F−, H2PO4−, and HP2O73−) by UV-vis and 1H NMR. The flexibility of these receptors allows a cooperative effect
    合成了一系列新的低聚亚甲基双(硝基苯基脲基苯甲酰胺)受体,改变了脲和酰胺基团(邻位 4和间位 8)的相对位置以及低聚亚甲基链的长度(C 2至 C 8)。通过 UV-vis 和1 H NMR对 TBAX 盐(X = AcO -、BzO -、F -、H 2 PO 4 -和 HP 2 O 7 3- )进行阴离子识别研究。这些受体的灵活性允许受体中两个脲基苯甲酰胺单元的协同作用。值得注意的是,邻位有利于与羧酸盐的配合物中的 1:1 化学计量。在这项工作中,与两种类型的受体4和8以及焦磷酸氢 形成 2 : 1 受体-阴离子复合物和获得的高 log K值非常重要。NMR 研究证明了超分子复合物的形成,即使在竞争性溶剂(如 DMSO)中也是如此。
  • A Mild and Clean Method for Oxidative Formation of Amides from Aldehydes and Amines
    作者:Weixing Qian、Weiliang Bao、Chen Fang
    DOI:10.1055/s-2008-1078218
    日期:——
    A metal-free direct oxidative formation of amides from aldehydes and amines using a hypervalent iodine(III) reagent or an ion-supported hypervalent iodine(III) reagent as a recyclable oxidant under mild conditions is reported.
    报道了使用高价碘 (III) 试剂或离子支持的高价碘 (III) 试剂作为可回收氧化剂在温和条件下从醛和胺中无金属直接氧化形成酰胺。
  • Carbacyclin analogues
    申请人:THE UPJOHN COMPANY
    公开号:EP0159784A1
    公开(公告)日:1985-10-30
    A compound of the formula and intermediates useful in preparing same.
    一种化合物的公式及其制备过程中有用的中间体。
  • 2, 4-pyrimidinediamine compounds and their uses
    申请人:Singh Rajinder
    公开号:US20050038243A1
    公开(公告)日:2005-02-17
    The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.
    本发明提供了抑制IgE和/或IgG受体信号级联,从而导致化学介质释放的2,4-嘧啶二胺化合物,以及合成这些化合物的中间体和方法,以及在多种情况下使用这些化合物的方法,包括在治疗和预防通过去颗粒化和其他由IgE和/或IgG受体信号级联激活的过程引起或与之相关的化学介质释放所表征的疾病中使用。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐